Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00029523
Status:
COMPLETED
Last Update Posted:
2007-02-28
First Post:
2002-01-15
Brief Title:
DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
Sponsor:
Pacira Pharmaceuticals Inc
Organization:
Pacira Pharmaceuticals Inc
Study Overview
Official Title:
A Randomized Clinical Study to Determine the Patient Benefit and Safety of Depocyt Cytarabine Liposome Injection for the Treatment of Neoplastic Meningitis
Status:
COMPLETED
Status Verified Date:
2007-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out how well an experimental drug called DepoCyt works for neoplastic meningitis cancer that has spread to the tissues around the brain and spinal cord DepoCyt is a new slow-release form of the cancer drug called ara-C cytarabine Cytarabine has been used for many years to treat cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None